Suppr超能文献

HNF4α--药物代谢中的作用及其作为潜在药物靶点的可能性?

HNF4α--role in drug metabolism and potential drug target?

机构信息

Genomics Research Center, Academia Sinica, Taipei 115, Taiwan.

出版信息

Curr Opin Pharmacol. 2010 Dec;10(6):698-705. doi: 10.1016/j.coph.2010.08.010.

Abstract

Hepatocyte nuclear factor 4α (HNF4α) is a highly conserved member of the nuclear receptor superfamily of ligand-dependent transcription factors. It is best known as a master regulator of liver-specific gene expression, especially those genes involved in lipid transport and glucose metabolism. However, there is also a growing body of work that indicates the importance of HNF4α in the regulation of genes involved in xenobiotic and drug metabolism. A recent study identifying the essential fatty acid linoleic acid (LA, C18:2) as the endogenous, reversible ligand for HNF4α suggests that HNF4α may also be a potential drug target and that its activity may be regulated by diet. This review will discuss the role of HNF4α in drug metabolism, including the genes it regulates, the factors that regulate its activity, and its potential as a drug target.

摘要

肝细胞核因子 4α(HNF4α)是核受体超家族配体依赖性转录因子的一个高度保守成员。它是肝脏特异性基因表达的主要调节因子,特别是那些涉及脂质转运和葡萄糖代谢的基因。然而,越来越多的工作表明 HNF4α在调节参与外来物和药物代谢的基因方面也很重要。最近的一项研究确定必需脂肪酸亚油酸(LA,C18:2)作为 HNF4α 的内源性、可逆配体,表明 HNF4α 也可能是一个潜在的药物靶点,其活性可能受饮食调节。这篇综述将讨论 HNF4α 在药物代谢中的作用,包括它调节的基因、调节其活性的因素以及作为药物靶点的潜力。

相似文献

1
HNF4α--role in drug metabolism and potential drug target?
Curr Opin Pharmacol. 2010 Dec;10(6):698-705. doi: 10.1016/j.coph.2010.08.010.
2
A transcriptional regulatory network of HNF4α and HNF1α involved in human diseases and drug metabolism.
Drug Metab Rev. 2022 Nov;54(4):361-385. doi: 10.1080/03602532.2022.2103146. Epub 2022 Jul 26.
4
Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription.
Drug Metab Pharmacokinet. 2008;23(1):2-7. doi: 10.2133/dmpk.23.2.
6
Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4alpha-deficient mice.
Mol Endocrinol. 2004 Aug;18(8):1975-87. doi: 10.1210/me.2004-0129. Epub 2004 May 20.
7
Hepatocyte nuclear factor 4alpha regulation of bile acid and drug metabolism.
Expert Opin Drug Metab Toxicol. 2009 Feb;5(2):137-47. doi: 10.1517/17425250802707342.
8
9
HNF4α in Hepatocyte Health and Disease.
Semin Liver Dis. 2023 May;43(2):234-244. doi: 10.1055/a-2097-0660. Epub 2023 May 22.

引用本文的文献

1
Orphan nuclear receptor transcription factors as drug targets.
Transcription. 2025 Apr-Jun;16(2-3):224-260. doi: 10.1080/21541264.2025.2521766. Epub 2025 Jul 11.
2
Hepatocyte nuclear factor 4-Alpha: a key regulator in liver carcinogenesis.
Cell Oncol (Dordr). 2025 Aug;48(4):885-897. doi: 10.1007/s13402-025-01064-7. Epub 2025 May 20.
3
Structure-based identification of HNF4α agonists: Rosmarinic acid as a promising candidate for NAFLD treatment.
Comput Struct Biotechnol J. 2024 Dec 27;27:171-183. doi: 10.1016/j.csbj.2024.12.014. eCollection 2025.
4
Molecular alterations associated with pathophysiology in liver-specific ZO-1 and ZO-2 knockout mice.
Cell Struct Funct. 2024 Oct 26;49(2):83-99. doi: 10.1247/csf.24046. Epub 2024 Sep 26.
5
Regulation of hepatic xenosensor function by HNF4alpha.
Toxicol Sci. 2024 Aug 1;200(2):346-356. doi: 10.1093/toxsci/kfae069.
6
Observational and genetic analyses clarify the relationship between type 2 diabetes mellitus and gallstone disease.
Front Endocrinol (Lausanne). 2024 Jan 31;14:1337071. doi: 10.3389/fendo.2023.1337071. eCollection 2023.
7
Impact of various high fat diets on gene expression and the microbiome across the mouse intestines.
Sci Rep. 2023 Dec 27;13(1):22758. doi: 10.1038/s41598-023-49555-7.
8
HNF4α isoforms regulate the circadian balance between carbohydrate and lipid metabolism in the liver.
Front Endocrinol (Lausanne). 2023 Dec 4;14:1266527. doi: 10.3389/fendo.2023.1266527. eCollection 2023.
9
The transcription factor HNF-4α: a key player in haematological disorders.
Arch Med Sci. 2021 Aug 13;19(6):1646-1652. doi: 10.5114/aoms/141219. eCollection 2023.
10
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC.
Nat Cancer. 2023 Sep;4(9):1362-1381. doi: 10.1038/s43018-023-00628-6. Epub 2023 Sep 7.

本文引用的文献

1
What are nuclear receptor ligands?
Mol Cell Endocrinol. 2011 Mar 1;334(1-2):3-13. doi: 10.1016/j.mce.2010.06.018. Epub 2010 Jul 6.
2
Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding.
Science. 2010 May 21;328(5981):1036-40. doi: 10.1126/science.1186176. Epub 2010 Apr 8.
5
MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle.
J Biol Chem. 2010 Feb 12;285(7):4415-22. doi: 10.1074/jbc.M109.085431. Epub 2009 Dec 15.
6
Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia.
J Biol Chem. 2010 Jan 29;285(5):3035-43. doi: 10.1074/jbc.M109.083899. Epub 2009 Dec 7.
8
CYP2D6 and tamoxifen: DNA matters in breast cancer.
Nat Rev Cancer. 2009 Aug;9(8):576-86. doi: 10.1038/nrc2683.
9
Sex differences in the expression of hepatic drug metabolizing enzymes.
Mol Pharmacol. 2009 Aug;76(2):215-28. doi: 10.1124/mol.109.056705. Epub 2009 May 29.
10
Identification of an endogenous ligand bound to a native orphan nuclear receptor.
PLoS One. 2009;4(5):e5609. doi: 10.1371/journal.pone.0005609. Epub 2009 May 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验